Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666236 | SCV000790494 | pathogenic | Xeroderma pigmentosum, group C | 2017-04-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001090470 | SCV001246036 | pathogenic | not provided | 2018-07-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001090470 | SCV001400167 | pathogenic | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro43Glnfs*36) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with xeroderma pigmentosum (PMID: 10766188). This variant is also known as fs43>378stop. ClinVar contains an entry for this variant (Variation ID: 551235). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000666236 | SCV004206986 | pathogenic | Xeroderma pigmentosum, group C | 2024-01-02 | criteria provided, single submitter | clinical testing |